Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
about
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Antiplatelet therapy with aspi ...... el, phase 3 superiority trial.
@en
Antiplatelet therapy with aspi ...... el, phase 3 superiority trial.
@nl
type
label
Antiplatelet therapy with aspi ...... el, phase 3 superiority trial.
@en
Antiplatelet therapy with aspi ...... el, phase 3 superiority trial.
@nl
prefLabel
Antiplatelet therapy with aspi ...... el, phase 3 superiority trial.
@en
Antiplatelet therapy with aspi ...... el, phase 3 superiority trial.
@nl
P2093
P2860
P50
P921
P1433
P1476
Antiplatelet therapy with aspi ...... el, phase 3 superiority trial.
@en
P2093
Alan A Montgomery
Graham S Venables
Hanne Christensen
Hugh S Markus
Jason P Appleton
Katie Flaherty
Lelia Duley
Lisa J Woodhouse
Maia Beridze
Marilyn James
P2860
P304
P356
10.1016/S0140-6736(17)32849-0
P407
P50
P577
2017-12-20T00:00:00Z